TGTX FY 2020 Earnings — TG Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

TGTXTG Therapeutics, Inc.

$5B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$152,000+0.0% YoY

Gross Profit

$152,000100.0% margin

Operating Income

-$274M-179996.1% margin

Net Income

-$279M-183803.3% margin

EPS (Diluted)

$-2.42

Cash Flow

Operating Cash Flow

-$215M

Free Cash Flow

-$215M

Stock-Based Comp.

$80M

Balance Sheet

Total Assets

$626M

Total Liabilities

$106M

Stockholders' Equity

$519M

Cash & Equivalents

$553M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$152,000	$152,000	+0.0%
Gross Profit	$152,000	$152,000	+0.0%
Operating Income	-$274M	-$169M	-61.8%
Net Income	-$279M	-$173M	-61.6%